![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
New technology may detect nucleic acid biomarkers of cancer
A new technique has been developed utilizing nanotechnology to detect disease biomarkers in the form...
UK Medical Research Council scientists create world’s first synthetic enzymes
Scientists at the UK's Medical Research Council (MRC) have created the world's first enzymes...
Hilleman signs MoU with Bangladesh firms to develop oral cholera vaccine
Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of...
FDA approves Amgen’s BLA for high cholesterol treatment evolocumab
Amgen has received approval for review from US Food and Drug Administration (FDA) for its...
Takeda and GE Healthcare partner to develop therapeutic drugs for liver diseases
Japan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development...
ex scientia Ltd. Partners with Sunovion Pharmaceuticals Inc. to Research New Medicines for Psychiatric...
exscientia Ltd. the polypharmacology driven drug discovery company announced today that they have signed...
AstraZeneca’s type 2 diabetes treatment Xigduo XR obtains FDA approvalAstraZeneca’s type 2 diabetes treatment...
British-Swedish drugmaker AstraZeneca has received approval from US Food and Drug Administration (FDA) for...
Pfizer’s Trumenba gets FDA accelerated approval to treat Meningococcal B disease
US-based drugmaker Pfizer has received accelerated approval from US Food and Drug Administration (FDA)...
Hikma to market Eisai’s epilepsy treatment Fycompa in Middle East
UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel)...
Gilead’s Harvoni receives FDA approval for hepatitis C genotype 1 infection
Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir...